Neurexis Therapeutics

📍 Aurora, United States👥 3 employees💰 Last funded 2020
Neurexis is developing an optimized peptide with demonstrated efficacy and safety in small and large animal models of global cerebral ischemia.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Neurexis Therapeutics?
Neurexis Therapeutics has 1 investor on record on gritt.io.
When did Neurexis Therapeutics last raise funding?
The most recent investment in Neurexis Therapeutics recorded on gritt.io was in 2020.
What industry is Neurexis Therapeutics in?
Neurexis Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Neurexis Therapeutics based?
Neurexis Therapeutics is headquartered in Aurora, United States.